Related Experiment Video
Updated: May 27, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Optimal deconvolution of transcriptional profiling data using quadratic programming with application to complex
Ting Gong1, Nicole Hartmann, Isaac S Kohane
1Biomarker Development, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America. ting.gong@novartis.com
This study introduces a novel computational method to accurately determine cell type proportions in complex biological samples. This approach enhances the analysis of molecular data from clinical trials, improving biomarker discovery and understanding of cellular processes.
Area of Science:
- Computational biology
- Genomics
- Biostatistics
Background:
- Molecular profiling aids biomarker discovery but complex human samples obscure analysis.
- Heterogeneity in clinical trial samples can negatively impact statistical studies.
- Accurate quantification of cell types is crucial for interpreting complex biological data.
Purpose of the Study:
- To develop and validate a computational method for deconvoluting cell type proportions from mixed-species transcriptional data.
- To address the challenge of sample heterogeneity in clinical trial molecular profiling.
- To improve the accuracy of statistical analyses on complex biological samples.
Main Methods:
- Utilized a linear latent variable model to represent mixed cell population expression as a weighted average of pure cell types.
- Employed quadratic programming for efficient, non-negative estimation of cell fractions.
- Applied the method to diverse platforms and benchmark datasets with known mixing fractions.
Main Results:
- Demonstrated accurate prediction of cell type mixing fractions on benchmark datasets.
- Successfully estimated proportions for over ten circulating cell types, including rare populations (<10%).
- Identified accurate leukocyte trafficking changes with Fingolomid (FTY720) treatment, consistent with prior methods.
Conclusions:
- The developed method effectively deconvolutes cell proportions from complex transcriptional data.
- This approach offers a robust solution for analyzing heterogeneity in clinical trial samples.
- The method enhances the reliability of molecular profiling for biomarker discovery and disease understanding.
Related Concept Videos
Statistical Software for Data Analysis and Clinical Trials
DNA Microarrays
Biostatistics: Overview
Discrete variables are...

